Abstract 15943: Health Status and Quality of Life With Early Invasive and Non-invasive Treatment Strategies for Patients With Claudication
Suveen Angraal(University of Missouri–Kansas City), Kim G. Smolderen(Yale University), John A. Spertus(Saint Luke's Health System), Vittal Hejjaji(Saint Luke's Hospital), Yuanyuan Tang(Saint Luke's Hospital), Carlos Mena‐Hurtado(Mount Sinai Hospital), Jan M.M. Heyligers(Elisabeth-TweeSteden Ziekenhuis), Rudolf Tutein Nolthenius(Albert Schweitzer Ziekenhuis), Herbert D. Aronow, J. Dawn Abbott(Brown University), Gregory L. Moneta(Oregon Health & Science University), Robert Fitridge(Royal Adelaide Hospital), William R. Hiatt(University of Colorado Denver), Peter Soukas(Northwestern University), Laith Derbas, Christopher J. White(Ochsner Medical Center), Manesh R. Patel(Duke University)
Cited by 0
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k